147 related articles for article (PubMed ID: 21046979)
21. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
[TBL] [Abstract][Full Text] [Related]
22. Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1.
Hassani M; Cai W; Holley DC; Lineswala JP; Maharjan BR; Ebrahimian GR; Seradj H; Stocksdale MG; Mohammadi F; Marvin CC; Gerdes JM; Beall HD; Behforouz M
J Med Chem; 2005 Dec; 48(24):7733-49. PubMed ID: 16302813
[TBL] [Abstract][Full Text] [Related]
23. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells.
Pickhardt M; Larbig G; Khlistunova I; Coksezen A; Meyer B; Mandelkow EM; Schmidt B; Mandelkow E
Biochemistry; 2007 Sep; 46(35):10016-23. PubMed ID: 17685560
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and molecular docking of substituted 3-hydrazinyl-3-oxo-propanamides as anti-tubercular agents.
Naqvi A; Malasoni R; Srivastava A; Pandey RR; Dwivedi AK
Bioorg Med Chem Lett; 2014 Nov; 24(22):5181-4. PubMed ID: 25442308
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of some p-toluenesulfonyl-hydrazinothiazoles and hydrazino-bis-thiazoles and their anticancer activity.
Zaharia V; Ignat A; Palibroda N; Ngameni B; Kuete V; Fokunang CN; Moungang ML; Ngadjui BT
Eur J Med Chem; 2010 Nov; 45(11):5080-5. PubMed ID: 20810194
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
29. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
30. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, Biological Evaluation and Molecular Docking Studies of 6-Aryl-2-Styrylquinazolin-4(3H)-Ones.
Agbo EN; Makhafola TJ; Choong YS; Mphahlele MJ; Ramasami P
Molecules; 2015 Dec; 21(1):E28. PubMed ID: 26712730
[TBL] [Abstract][Full Text] [Related]
32. A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.
Park H; Kim YJ; Hahn JS
Bioorg Med Chem Lett; 2007 Nov; 17(22):6345-9. PubMed ID: 17869098
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors.
Ibrahim DA; El-Metwally AM
Eur J Med Chem; 2010 Mar; 45(3):1158-66. PubMed ID: 20045222
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents.
Zhang J; Zhang Y; Shan Y; Li N; Ma W; He L
Eur J Med Chem; 2010 Jul; 45(7):2798-805. PubMed ID: 20304537
[TBL] [Abstract][Full Text] [Related]
35. Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines.
Sousa E; Paiva A; Nazareth N; Gales L; Damas AM; Nascimento MS; Pinto M
Eur J Med Chem; 2009 Sep; 44(9):3830-5. PubMed ID: 19428155
[TBL] [Abstract][Full Text] [Related]
36. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents.
Benassi L; Magnoni C; Giudice S; Bertazzoni G; Costi MP; Rinaldi M; Venturelli A; Coppi A; Rossi T
Anticancer Res; 2006; 26(5A):3499-504. PubMed ID: 17094473
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
Rostom SA; Hassan GS; El-Subbagh HI
Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
